Offline mode

Intended Purpose
The Free Testosterone ELISA is intended for the measurement of free testosterone in serum in adults. Measurement of free testosterone is an aid in diagnosis of hormone imbalance that results in various clinical conditions like hypogonadism (androgen deficiency) in men and hypergonadism (excess of androgen hormones) e.g. polycystic ovaries in women. The Free Testosterone ELISA is a solid phase enzyme-linked immunosorbent assay (ELISA), based on the principle of competitive binding and measured on an absorbance reader. The assay is semi-automated requiring general purpose laboratory instruments and consumables such as absorbance microplate reader/washer, vortexer and pipettes to execute the test. The assay is adaptable by laboratory personnel to automate on open ELISA-based liquid handler platforms like EVOlyzer or DSX; however, the programming of the steps and timing required by the manual kit assay test instructions must be strictly adhered to and verified by the laboratory. Test results may be calculated from a standard curve and compared to laboratory-established reference ranges from healthy adults (i.e. normal ranges). The test kit is intended for professional laboratory use by trained personnel. The test kit is not for home or layperson use. The Free Testosterone ELISA is NOT intended for point-of-care settings.

Clinical significance
Testosterone is a pleiotropic hormone [1], meaning it affects different phenotypes and plays an important role in the human body. It is a C19-steroid and the most effective natural hormone in the family of androgens. Testosterone in men is produced by the testes as well minimally by the adrenal cortex. In women testosterone derives from the production in the adrenal cortex and ovaries, accounting for 50 % of testosterone, while the remainder is produced from peripheral tissues such as bone, breast, muscle, and fat. [2] Like other steroid hormones, testosterone concentrations follow a diurnal rhythm, with testosterone levels peaking in the morning and declining during the day. [3] Roughly 1 - 5 % of free testosterone are present in serum of healthy individuals with 38 % albumin-bound testosterone, and 60 % sex hormone-binding globulin (SHBG)-bound testosterone; where the latter two are typically unable to enter the intracellular environment and exert their biochemical effects [4; 5]. To determine the level of testosterone, it is relevant to measure the free fraction [7] because it is biologically active [6] and it can be performed in bodily fluids like plasma or serum. Measuring testosterone plays a vital role in the diagnosis of different endocrine disorders. [1] An increased testosterone level can be due to testicular or pituitary abnormalities [7] or androgen abuse in men. A decline in hormone production including testosterone can be observed in aging men who experience a variety of symptoms with declining testosterone levels e.g. thinning hair, loss of vigor or sexual dysfunction. [8] Measurement in women is applied as an aid to diagnose clinical hypogonadism and to help diagnose hyperandrogenic states e.g., hirsutism, ovarian failure [9] and infant congenital adrenal hyperplasia [10], ovarian or adrenal neoplasm, polycystic ovarian syndrome. [11; 12]

For concrete data please consult the Instruction for Use in the download box on the top right side.

  1. Tygi, V., Scordo, M., Yoon, R. S., Liporace, F. A., & Greene, L. W. (2017). Revisiting the role of testosterone: Are we missing something?. Reviews in urology, 19(1), 16
  2. Burger, H. G. (2002). Androgen production in women. Fertility and sterility, 77, 3-5.
  3. Brambilla, D. J., Matsumoto, A. M., Araujo, A. B., & McKinlay, J. B. (2009). The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. The Journal of Clinical Endocrinology & Metabolism, 94(3), 907-913.
  4. DeVan, M. L., Bankson, D. D., & Abadie, J. M. (2008). To what extent are free testosterone (FT) values reproducible between the two Washingtons, and can calculated FT be used in lieu of expensive direct measurements?. American journal of clinical pathology, 129(3), 459-463.
  5. Brooks, R. V. (1975). 1 Androgens. Clinics in endocrinology and metabolism, 4(3), 503- 520.
  6. Shea, J. L., Wong, P. Y., & Chen, Y. (2014). Free testosterone: clinical utility and important analytical aspects of measurement. Advances in clinical chemistry, 63, 59-84.
  7. Kumar, P., Kumar, N., Thakur, D. S., & Patidar, A. (2010). Male hypogonadism: Symptoms and treatment. Journal of advanced pharmaceutical technology & research, 1(3), 297.
  8. Clifton, S., Macdowall, W., Copas, A. J., Tanton, C., Keevil, B. G., Lee, D. M., ... & Wu, F. C. W. (2016). Salivary testosterone levels and health status in men and women in the British general population: findings from the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). The Journal of Clinical Endocrinology & Metabolism, 101(11), 3939- 3951.
  9. Wood, P. (2009). Salivary steroid assays–research or routine?. Annals of clinical biochemistry, 46(3), 183-196.
  10. New, M. I., & Josso, N. (1988). Disorders of gonadal differentiation and congenital adrenal hyperplasia. Endocrinology and metabolism clinics of North America, 17(2), 339-366.
  11. Dumesic, D. A. (1995). Hyperandrogenic anovulation: A new view of polycystic ovary syndrome. Postgrad. Obstet. Gynecol, 15, 1-6.
  12. Škrgatić, L., & Trgovčić, I. (2013). Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome. Acta dermatovenerologica Croatica: ADC, 21(2), 105-112.

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.